SIRT1 and diabetic kidney disease: Actually, activation of SIRT1 by T2 ameliorates diabetic nephropathy in rats [118], and SIRT1-activation by the specific agonist SRT1720 in mice and by T2 in rats has been shown to result in indirect activation of AMPK in the longer term [21,113].